Skip to main content
Erschienen in: Clinical and Experimental Medicine 4/2018

20.06.2018 | Review Article

Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review

verfasst von: Giovanna Di Meo, Lucia Ilaria Sgaramella, Valentina Ferraro, Francesco Paolo Prete, Angela Gurrado, Mario Testini

Erschienen in: Clinical and Experimental Medicine | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of this report was to illustrate a case of parathyroid carcinoma (PC) in a patient with multiple endocrine neoplasia type 1 (MEN1) along with a comprehensive literature review. A 61-year-old man presented with 9-cm PC causing primary hyperparathyroidism (PHPT). His pre-operative corrected calcium and intact PTH serum levels were 2.92 mmol/L and 391.7 pg/mL, respectively. The neoplastic gland was removed in bloc with thyroid and central compartment lymph nodes. A literature review was run by searching PubMed MEDLINE from 1977 to 2018 for studies of all types, in the English language only, using the terms “Parathyroid, carcinoma, Multiple endocrine neoplasia, type 1, (MEN1).” Pathology confirmed PC. Post-operative calcium and PTH levels were normal. A diagnosis of MEN1 was established post-operatively. Seventeen cases of PC in patients with MEN1 have been reported in the literature. 59% of patients were men, and median age at diagnosis was 50 years, with median serum PTH of 379 pg/mL and median serum calcium level of 3.2 mmol/L. The occurrence of PC in the context of MEN1 is extremely rare. Diagnosis and treatment may represent a challenge, so opportune identification or suspicion of malignancy and adoption of correct surgical approach may offer affected patients the best outcome.
Literatur
1.
Zurück zum Zitat Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985 and 1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86:538–44.CrossRef Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985 and 1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86:538–44.CrossRef
2.
3.
Zurück zum Zitat Wu CW, Huang CI, Tsai ST, Chiang H, Lui WY, P’eng FK. Parathyroid carcinoma in a patient with non-secretory pituitary tumor: a variant of multiple endocrine neoplasia type-I? Eur J Surg Oncol. 1992;18:517–20.PubMed Wu CW, Huang CI, Tsai ST, Chiang H, Lui WY, P’eng FK. Parathyroid carcinoma in a patient with non-secretory pituitary tumor: a variant of multiple endocrine neoplasia type-I? Eur J Surg Oncol. 1992;18:517–20.PubMed
4.
Zurück zum Zitat Sato M, Miyauchi A, Namihira H, et al. A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma. Endocrine. 2000;12:223–6.CrossRef Sato M, Miyauchi A, Namihira H, et al. A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma. Endocrine. 2000;12:223–6.CrossRef
5.
Zurück zum Zitat Dionisi S, Minisola S, Pepe J, et al. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc. 2002;77:866–9.CrossRef Dionisi S, Minisola S, Pepe J, et al. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc. 2002;77:866–9.CrossRef
6.
Zurück zum Zitat Agha A, Carpenter R, Bhattacharya S, Edmonson SJ, Carlsen E, Monson JP. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. J Endocrinol Investig. 2007;30:145–9.CrossRef Agha A, Carpenter R, Bhattacharya S, Edmonson SJ, Carlsen E, Monson JP. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. J Endocrinol Investig. 2007;30:145–9.CrossRef
7.
Zurück zum Zitat Shih RY, Fackler S, Maturo S, True MW, Brennan J, Wells D. Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation. Endocr Pract. 2009;15:567–72.CrossRef Shih RY, Fackler S, Maturo S, True MW, Brennan J, Wells D. Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation. Endocr Pract. 2009;15:567–72.CrossRef
8.
Zurück zum Zitat Kalavalapalli S, Talapatra I, Patrick I. A complex case of multiple endocrine neoplasia type 1 with metastatic parathyroid carcinoma. Cent Eur J Med. 2010;5:53–8. Kalavalapalli S, Talapatra I, Patrick I. A complex case of multiple endocrine neoplasia type 1 with metastatic parathyroid carcinoma. Cent Eur J Med. 2010;5:53–8.
9.
Zurück zum Zitat del Pozo C, García-Pascual L, Balsells M, et al. Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature. Hormones. 2011;10:326–31.CrossRef del Pozo C, García-Pascual L, Balsells M, et al. Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature. Hormones. 2011;10:326–31.CrossRef
10.
Zurück zum Zitat Juodelė L, Serapinas D, Sabaliauskas G, et al. Carcinoma of two parathyroid glands caused by a novel MEN1 gene mutation—a rare feature of the MEN 1 syndrome. Medicina. 2011;47:635–9.CrossRef Juodelė L, Serapinas D, Sabaliauskas G, et al. Carcinoma of two parathyroid glands caused by a novel MEN1 gene mutation—a rare feature of the MEN 1 syndrome. Medicina. 2011;47:635–9.CrossRef
11.
Zurück zum Zitat Lee KM, Kim EJ, Choi WS, Park WS, Kim SW. Intrathyroidal parathyroid carcinoma mimicking a thyroid nodule in a MEN type 1 patient. J Clin Ultrasound. 2014;42:212–4.CrossRef Lee KM, Kim EJ, Choi WS, Park WS, Kim SW. Intrathyroidal parathyroid carcinoma mimicking a thyroid nodule in a MEN type 1 patient. J Clin Ultrasound. 2014;42:212–4.CrossRef
12.
Zurück zum Zitat Christakis I, Busaidy NL, Cote GJ, et al. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; a clinico-pathologic challenge. The MD Anderson case series and review of the literature. Int J Surg. 2016;31:10–6.CrossRef Christakis I, Busaidy NL, Cote GJ, et al. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; a clinico-pathologic challenge. The MD Anderson case series and review of the literature. Int J Surg. 2016;31:10–6.CrossRef
14.
Zurück zum Zitat Cinque L, Sparaneo A, Cetani F, et al. Novel association of MEN1 gene mutations with parathyroid carcinoma. Oncol Lett. 2017;14:23–30.CrossRef Cinque L, Sparaneo A, Cetani F, et al. Novel association of MEN1 gene mutations with parathyroid carcinoma. Oncol Lett. 2017;14:23–30.CrossRef
15.
Zurück zum Zitat Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):485–93.CrossRef Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):485–93.CrossRef
16.
Zurück zum Zitat Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96(12):3679–86.CrossRef Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96(12):3679–86.CrossRef
17.
Zurück zum Zitat Goldfarb M, O’Neal P, Shih JL, Hartzband P, Connolly J, Hasselgren PO. Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism. Endocr Pract. 2009;15(5):463–8.CrossRef Goldfarb M, O’Neal P, Shih JL, Hartzband P, Connolly J, Hasselgren PO. Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism. Endocr Pract. 2009;15(5):463–8.CrossRef
18.
Zurück zum Zitat Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973;31(3):600.CrossRef Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973;31(3):600.CrossRef
19.
Zurück zum Zitat DeLellis RA. Parathyroid carcinoma: an overview. Adv Anat Pathol. 2005;12:53–61.CrossRef DeLellis RA. Parathyroid carcinoma: an overview. Adv Anat Pathol. 2005;12:53–61.CrossRef
20.
Zurück zum Zitat LiVolsi VA. Pathology of the parathyroid gland. In: Barnes L, editor. Surgical pathology of the head and neck. New York: Marcel Dekker; 1985. p. 1487. LiVolsi VA. Pathology of the parathyroid gland. In: Barnes L, editor. Surgical pathology of the head and neck. New York: Marcel Dekker; 1985. p. 1487.
21.
Zurück zum Zitat Ippolito G, Palazzo FF, Sebag F, De Micco C, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg. 2007;94:566–70.CrossRef Ippolito G, Palazzo FF, Sebag F, De Micco C, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg. 2007;94:566–70.CrossRef
22.
Zurück zum Zitat Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97:2990–3011.CrossRef Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97:2990–3011.CrossRef
23.
Zurück zum Zitat Guerrero MA. Cryopreservation of parathyroid glands. Int J Endocrinol. 2010;2010:829540.CrossRef Guerrero MA. Cryopreservation of parathyroid glands. Int J Endocrinol. 2010;2010:829540.CrossRef
24.
Zurück zum Zitat Cavallaro G, Iorio O, Centanni M, et al. Parathyroid reimplantation in forearm subcutaneous tissue during thyroidectomy: a simple and effective way to avoid hypoparathyroidism. World J Surg. 2015;39:1936–42.CrossRef Cavallaro G, Iorio O, Centanni M, et al. Parathyroid reimplantation in forearm subcutaneous tissue during thyroidectomy: a simple and effective way to avoid hypoparathyroidism. World J Surg. 2015;39:1936–42.CrossRef
25.
Zurück zum Zitat Testini M, Rosato L, Avenia N, et al. The impact of single parathyroid gland autotransplantation during thyroid surgery on postoperative hypoparathyroidism: a multicenter study. Transplant Proc. 2007;39:225–30.CrossRef Testini M, Rosato L, Avenia N, et al. The impact of single parathyroid gland autotransplantation during thyroid surgery on postoperative hypoparathyroidism: a multicenter study. Transplant Proc. 2007;39:225–30.CrossRef
26.
Zurück zum Zitat Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86:378–80.CrossRef Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86:378–80.CrossRef
27.
Zurück zum Zitat Owen RP, Silver CE, Pellitteri PK, et al. Parathyroid carcinoma: a review. Head Neck. 2011;33:429–36.PubMed Owen RP, Silver CE, Pellitteri PK, et al. Parathyroid carcinoma: a review. Head Neck. 2011;33:429–36.PubMed
28.
Zurück zum Zitat Schulte KM, Talat N, Miell J, Moniz C, Sinha P, Diaz-Cano S. Lymph node involvement and surgical approach in parathyroid cancer. World J Surg. 2010;34:2611–20.CrossRef Schulte KM, Talat N, Miell J, Moniz C, Sinha P, Diaz-Cano S. Lymph node involvement and surgical approach in parathyroid cancer. World J Surg. 2010;34:2611–20.CrossRef
29.
Zurück zum Zitat Munson ND, Foote RL, Northcutt RC, et al. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer. 2003;98:2378–84.CrossRef Munson ND, Foote RL, Northcutt RC, et al. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer. 2003;98:2378–84.CrossRef
30.
Zurück zum Zitat Busaidy NL, Jimenez C, Habra MA, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716–26.CrossRef Busaidy NL, Jimenez C, Habra MA, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716–26.CrossRef
31.
Zurück zum Zitat Iacobone M, Citton M, Viel G, Schiavone D, Torresan F. Surgical approaches in hereditary endocrine tumors. Updates Surg. 2017;69:181–91.CrossRef Iacobone M, Citton M, Viel G, Schiavone D, Torresan F. Surgical approaches in hereditary endocrine tumors. Updates Surg. 2017;69:181–91.CrossRef
Metadaten
Titel
Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review
verfasst von
Giovanna Di Meo
Lucia Ilaria Sgaramella
Valentina Ferraro
Francesco Paolo Prete
Angela Gurrado
Mario Testini
Publikationsdatum
20.06.2018
Verlag
Springer International Publishing
Erschienen in
Clinical and Experimental Medicine / Ausgabe 4/2018
Print ISSN: 1591-8890
Elektronische ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-018-0512-7

Weitere Artikel der Ausgabe 4/2018

Clinical and Experimental Medicine 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.